Thromboprophylaxis during labour and delivery

Slides:



Advertisements
Similar presentations
Enhanced Recovery in Thoracic Surgery Referral Managing pre- existing medical conditions Informed decision making Pre-operative Health & risk assessment.
Advertisements

Thromboprophylaxis after delivery
Vanderbilt Pediatric Hematology Anticoagulation Guidance Protocol Robert F. Sidonio, Jr. MD, MSc. 4/11/12 Enoxaparin Dosing Goal anti-Xa levels are 0.6.
Puerperal fever IG: Sio Cheong Un IG: Sio Cheong Un 2011/4/4 2011/4/4.
Chapter Six Venous Disease Coalition Acute Management of VTE VTE Toolkit.
VTE in abdominal-pelvic surgery patients
Antithrombotic Therapy for Venous Thromboembolic Diseases
Venous Thromboembolism Prevention August Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for.
Prophylaxis of Venous Thromboembolism
Best Practices in Meeting NPSG 3E-Anticoagulation Requirements MaryAnne Cronin, PharmD Assistant Director of Pharmacy Glen Cove Hospital.
Increasingly, women who are asymptomatic present in pregnancy with a known thrombophilia, typically detected because of screening following identification.
ANAESTHESIA AND ANTICOAGULANTS
Regional Anesthetics and Anticoagulation Marie Sankaran Raval M.D. Boston Medical Center Department of Anesthesiology Nina Zachariah M.D.
MANAGEMENT OF THE OBESE PREGNANT PATIENT Max Brinsmead PhD FRANZCOG May 2010.
CHEST-2012: High Points and Pearls Alan Brush, MD, FACP Chief, Anticoagulation Management Service Harvard Vanguard Medical Associates.
LIFEBLOOD THE Thrombosis CHARITY Venous thromboembolism – Treatment and secondary prevention Ulcus cruris Chronic PE PE DVT Post-thrombotic syndrome Death.
Volume 359: November 6, 2008 Number 19November 6, 2008.
Management thrombophilia. introduction Twenty percent of maternal deaths in the United States during that period were attributed to PE. Inherited thrombophilias.
Peri-operative management of anticoagulation Marc Carrier MD, MSc FRCPC Assistant Professor, University of Ottawa Associate Scientist, Ottawa Health Research.
PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM
Thromboprophylaxis in Pregnancy and the Puerperium
Obstetric Haemorrhage. Aims To recognise Obstetric Haemorrhage To recognise Obstetric Haemorrhage To practise the skills needed to respond to a woman.
April 23, 2015 Mini-Lecture Nathan King M.D. Anticoagulation Reversal Part 2: UFH & LMWH.
7th ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based Guidelines.
INR for warfarin monitoring ©bpac nz, October 2006.
PERIOPERATIVE MANAGEMENT OF A PARTURIENT WITH PRIOR H/O PULMONARY EMBOLISM AND IVC FILTER IN SITU DR.KRANAPPU SOLOMON,DNB PG DR.RENU DEVAPRASATH,DNB (Anesth)
VENOUS THROMBOEMBOLISM IN PREGNANCY BY Dr. YASSER AL-AHMADI.
PRE-OPERATIVE PRE - MEDICATION. Pre-medication  Pre-medication is the administration of drugs before anesthesia.  Pre-medication is used to prepare.
Pregnancy care in women with BMI>35 Dr S Sharma, Dr A Mahmud and Dr N Manheri-OthayothUniversity Hospital of Wales, Cardiff UK Pregnancy care in women.
Deep vein thrombosis Pulmonary embolism Deep vein thrombosis Pulmonary embolism Venous Thromboembolism TreatmentTreatment …All the same?
IVC filters what you need to know Sam Chakraverty Consultant Radiologist Ninewells Hospital Dundee, Scotland.
TRIAL OF SCAR Is it ethical ? Is VBAC a legitimate aim for 2002 ? P. A Onyango- Okeyo Dept of Obstetrics & Gynaecology University of Witwatersrand.
Peri-Operative anticoagulation /antiplatelet therapy A Shift in Paradigm BMHGT04/29/09.
VTE in OBGYN practice DR ANBU SUBBIAN
Drugs Susan Louw Haematology Registrar. 4 Questions to ask: Can I stop? (What is the risk of thrombosis?) Should I stop? (What is the risk of bleeding?)
Diabetes in pregnancy Timing and Mode of Delivery
به نام خد ا. روش های زایمان و ختم حاملگی در بیماران روماتیسمی.
Postpartum period in women with systemic lupus erythematosus BY DR KH ELMIZADEH.
Thromboprophylaxis in pregnancy: Cardiff and Vale’s approach and the reasons why Rachel Rayment, Consultant Haematologist, UHW
Fundamental Research in Oncology & Thrombosis FRONTLINE 1 Survey.
Information and advice: the risks and benefits of vaginal birth, induction of labour and caesarean section if the baby has macrosomia.
Outpatient DVT assessment & treatment Daniel Gilada.
THROMBOEMBOLIC DISEASE IN PREGNANCY AND PUERPERIUM DR ASHRAF ATIA DEWIDAR MD MRCOG.
Dr. Hadab A. Mohamed. BACKGROUND Temporary interruption Thrombotic risk Continuation Bleeding risk A great challenge, especially in the emergency setting.
Venous thrombosis Dr.mousa Qasim hussein Assistant professor Dep. of internal medicine 10 April 2016.
Introduction - Perioperative management of patients on warfarin or antiplatelet therapy involves assessing and balancing individual risks for thromboembolism.
Akram Sardari.MD Fellowship Of Echocardiography Imam Khomeini Hospital VALVULAR DISEASE IN PREGNANCY.
POSTPARTUM HAEMORRHAGE
Vital statistics in obstetrics.
By: Dr. Nalaka Gunawansa
Emergency Care Part 3: Surgery in Children with Diabetes
Sickle cell disease -refers to a group of disorders arising from defective genes that produce abnormal Hb molecules (HbS). -Defective genes produce abnormal.
OPERATIVE VAGINAL DELIVERIES AND CAESAREAN SECTION (C.S)
Dr Ferdous Mehrabian. Dr Ferdous Mehrabian Inherited thrombophilias in pregnancy Inherited thrombophilias is a genetic tendency to venous thrombosis.
The normal haemostasis process involves three stages: 1
Presented by :Jaber Manasia
Prevention and Management of Venous Thromboembolic Events in Patients With Multiple Myeloma.
Section F: Clinical guidelines
1000 lives + Mini Collaborative: Community Bundle
Periprocedural Management of Patients on Anticoagulation
Vaginal birth after caesarean section (VBAC)
Birth after Caesarean Making your decision
How I treat cancer-associated venous thromboembolism
In the name of GOD.
Thrombophilia in pregnancy: Whom to screen, when to treat
Emergency Care Part 3: Surgery in Children with Diabetes
Sickle cell disease -refers to a group of disorders arising from defective genes that produce abnormal Hb molecules (HbS). -Defective genes produce abnormal.
Prevention and Management of Venous Thromboembolic Events in Patients With Multiple Myeloma.
Treatment algorithm. Treatment algorithm. (A) Suggested treatment algorithm for symptomatic and incidental DVT or PE in cancer patients. (B) Suggested.
Breech Presentation Dr Madhavi Kalidindi
Presentation transcript:

Thromboprophylaxis during labour and delivery

When should thromboprophylaxis be interrupted for delivery Women receiving antenatal LMWH should be advised that if they have any vaginal bleeding or once labour begins, they should not inject any further LMWH. They should be reassessed on admission to hospital and further doses should be prescribed by medical staff.

The pregnancy-associated prothrombotic changes in the coagulation system are maximal immediately following delivery. It is therefore desirable to continue LMWH during labour or delivery in women receiving antenatal thromboprophylaxis with LMWH. However, to allow for the use of regional analgesia or anaesthesia if requested or required, women are advised to discontinue LMWH at the onset of labour .

For women receiving high prophylactic or therapeutic doses of LMWH, the dose of heparin should be reduced to its thromboprophylactic dose on the day before induction of labour and, if appropriate, continued in this dose during labour

Regional anaesthesia or analgesia can be sited only after discussion with a senior anaesthetist. -

to minimise or avoid the risk of epidural haematoma : Regional techniques should not be used until at least 12 hours after the previous prophylactic dose of LMWH When a woman presents while on a therapeutic regimen of LMWH, regional techniques should not be employed for at least 24 hours after the last dose of LMWH LMWH should not be given for 4 hours after use of spinal anaesthesia or after the epidural catheter has been removed; the cannula should not be removed within 10–12 hours of the most recent injection

delivery by elective caesarean section For delivery by elective caesarean section in women receiving antenatal LMWH, the woman should receive a thromboprophylactic dose of LMWH on the day before delivery. On the day of delivery, any morning dose should be omitted and the operation should be performed that morning.

Cont… The thromboprophylactic dose of LMWH should be given 4 hours post-operatively or 4 hours after removal of the epidural catheter.

Cont… If antenatal LMWH is routinely prescribed at 6pm, this allows for an elective caesarean section the next morning, removal of the epidural catheter before 2pm and a first postnatal dose of LMWH at 6pm the same day.

Women those take treatment dose : In women those on high-dose prophylactic or treatment doses of LMWH , there may be an indication for induction of labour to help plan thromboprophylaxis around delivery

Cont… for example, if the woman takes the morning dose but omits the evening dose on the day before induction of labour , she could have an early elective epidural sited the next day (when it will be 24 hours since her last dose of LMWH).

If LMWH precludes regional techniques: the woman who presents in spontaneous labour within 12 hours of taking a LMWH , alternative analgesia such as opiate-based intravenous analgesia can be offered. There is an increased risk of wound haematoma following caesarean section with both unfractionated and LMWH around 2% .

excess blood loss and blood transfusion is a risk factor for VTE, so thromboprophylaxis should be begun or reinstituted as soon as the immediate risk of haemorrhage is reduced.

Women at high risk of haemorrhage : Women at high risk of haemorrhage with risk factors including major antepartum haemorrhage, coagulopathy, progressive wound haematoma, suspected intra-abdominal bleeding and postpartum haemorrhage may be more conveniently managed with unfractionated heparin or graduated compression stockings .

women who are at high risk for recurrent VTE : A period of 24-36 h without anticoagulant therapy may be undesirable In pregnant women who are at high risk for recurrent VTE (acute PE or proximal DVT during last month) ; Such patient may benefit from having their sc LMWH or SC UFH switched to IV UFH ,which can be discontinued 4 to 6 h prior delivery. (Up to date)

Cont… The clinician may be unwilling to tolerate even a short interval without anticoagulant therapy , such as a patient with reduced cardiopulmonary reserve and a recent PE A temporary IVC filter can be inserted in this situation ,or delivery can proceed despite full anticoagulation .

In cases in which preterm delivery is anticipated ,it is common to discontiue SC LMWH or SC UFH at 36 wk and IV UFH is then instead .

If spontaneous labour occurs in women receiving therapeutic doses of subcutaneous unfractionated heparin : careful monitoring of the APTT is required If it is markedly prolonged near delivery, protamine sulfate may be required to reduce the risk of bleeding.

UFH Subcutaneous unfractionated heparin should be discontinued 12 hours before and intravenous unfractionated heparin stopped 6 hours before induction of labour or regional anaesthesia

UFH… Any woman who is considered to be at high- risk of haemorrhage and in whom continued heparin treatment is considered essential , should be managed with intravenous, unfractionated heparin until the risk factors for haemorrhage have resolved.

UFH… Unfractionated heparin has a shorter half-life than LMWH and its activity is more completely reversed with protamine sulphate.

Are specific surgical measures required for anticoagulated women undergoing delivery by caesarean section? In women receiving therapeutic doses of LMWH, wound drains (abdominal and rectus sheath) should be considered at caesarean section and the skin incision should be closed with staples or interrupted sutures to allow drainage of any haematoma.

Delivery despite full anticoagulation may also occure if labor begins unexpectedly. Delivery while anticoagulated will not have excessive intrapartum bleeding